Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Shouguang Fukang Pharmaceutical Co., Ltd..
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Shouguang Fukang Pharmaceutical Co., Ltd.: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.
Side by side
Philips North America — Warning letters0
Shouguang Fukang Pharmaceutical Co., Ltd. — Warning letters0
Philips North America — Recalls355
Shouguang Fukang Pharmaceutical Co., Ltd. — Recalls0
Philips North America — Approval records0
Shouguang Fukang Pharmaceutical Co., Ltd. — Approval records0
Philips North America — Form 483s0
Shouguang Fukang Pharmaceutical Co., Ltd. — Form 483s1
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Philips North America vs Shouguang Fukang Pharmaceutical Co., Ltd.: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/philips-north-america-vs-shouguang-fukang-pharmaceutical-co-ltd
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗